Mehebubar Rahaman
Overview
Explore the profile of Mehebubar Rahaman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
170
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bhattacharyya A, Kamran M, Ejazi S, Das S, Didwania N, Bhattacharjee R, et al.
Pathogens
. 2022 Feb;
11(2).
PMID: 35215064
Visceral leishmaniasis (VL) is one of the major global health concerns due to its association with morbidity and mortality. All available diagnostic tools have been, until now, unable to provide...
2.
Ejazi S, Choudhury S, Bhattacharyya A, Kamran M, Pandey K, Das V, et al.
Microorganisms
. 2021 Jul;
9(7).
PMID: 34201902
Visceral leishmaniasis (VL), a fatal parasitic infection, is categorized as being neglected among tropical diseases. The use of conventional tissue aspiration for diagnosis is not possible in every setting. The...
3.
Kamran M, Ejazi S, Choudhury S, Bhattacharyya A, Tanishka K, Pandey K, et al.
Clin Infect Dis
. 2021 May;
73(7):1281-1283.
PMID: 33987660
Tests for visceral leishmaniasis (VL) are not uniformly effective for all endemic regions. In a serological assay, a novel antigen, otubain cysteine peptidase, compared with rK39, showed comparable sensitivity with...
4.
Ejazi S, Ghosh S, Saha S, Choudhury S, Bhattacharyya A, Chatterjee M, et al.
Sci Rep
. 2021 Feb;
11(1):3967.
PMID: 33574485
No abstract available.
5.
Didwania N, Ejazi S, Chhajer R, Sabur A, Mazumder S, Kamran M, et al.
J Clin Microbiol
. 2020 Aug;
58(11).
PMID: 32848039
Visceral leishmaniasis (VL) is a threat in many developing countries. Much effort has been put to eliminating this disease, for which serodiagnosis remains the mainstay for VL control programs. New...
6.
Ejazi S, Ghosh S, Bhattacharyya A, Kamran M, Das S, Bhowmick S, et al.
Parasit Vectors
. 2020 Jun;
13(1):272.
PMID: 32473634
Background: Visceral leishmaniasis (VL), is a parasitic disease that causes serious medical consequences if treatment is delayed. Despite a decline in the number of VL cases in the Indian subcontinent,...
7.
Ejazi S, Ghosh S, Saha S, Choudhury S, Bhattacharyya A, Chatterjee M, et al.
Sci Rep
. 2019 Jul;
9(1):9932.
PMID: 31289323
Visceral leishmaniasis (VL) is one of the leading infectious diseases affecting developing countries. Colloidal gold-based diagnostic tests are rapid tools to detect blood/serum antibodies for VL diagnosis. Lack of uniformity...
8.
Ejazi S, Bhattacharyya A, Choudhury S, Ghosh S, Sabur A, Pandey K, et al.
Sci Rep
. 2018 Aug;
8(1):12110.
PMID: 30108316
Visceral leishmaniasis (VL), a potentially fatal disease is an outcome of infection caused by the parasite Leishmania donovani. The clinical diagnostic tests for this disease are still related to invasive...
9.
Ejazi S, Bhattacharya P, Bakhteyar M, Mumtaz A, Pandey K, Das V, et al.
PLoS Negl Trop Dis
. 2016 Oct;
10(10):e0005035.
PMID: 27741241
Background: Visceral Leishmaniasis (VL), a severe parasitic disease, could be fatal if diagnosis and treatment is delayed. Post kala-azar dermal leishmaniasis (PKDL), a skin related outcome, is a potential reservoir...
10.
Bhattacharya P, Ghosh S, Ejazi S, Rahaman M, Pandey K, Das V, et al.
PLoS Negl Trop Dis
. 2016 Feb;
10(2):e0004422.
PMID: 26829554
Background: Visceral leishmaniasis (VL) is distinguished by a complex interplay of immune response and parasite multiplication inside host cells. However, the direct association between different immunological correlates and parasite numbers...